A Single Intranasal Dose of Bacterial Therapeutics to Calves Confers Longitudinal Modulation of the Nasopharyngeal Microbiota
S. Amat, E. Timsit, M. Workentine, T. Schwinghamer, F. van der Meer, Y. Guo, T. Alexander
Abstract
To address the emergence of antimicrobial-resistant pathogens in livestock, microbiome-based strategies are increasingly being sought to reduce antimicrobial use. Here, we describe the intranasal application of bacterial therapeutics (BTs) for mitigating bovine respiratory disease (BRD) and used structural equation modeling to investigate the causal networks after BT application. Beef cattle received i) an intranasal cocktail of previously characterized BT strains, ii) an injection of metaphylactic antimicrobial (tulathromycin), or iii) intranasal saline. Despite being transient colonizers, inoculated BT strains induced longitudinal modulation of the nasopharyngeal bacterial microbiota while showing no adverse effect on animal health. The BT-mediated changes in bacteria included reduced diversity and richness and strengthened cooperative and competitive interactions. In contrast, tulathromycin increased bacterial diversity and antibiotic resistance, and disrupted bacterial interactions. Overall, a single intranasal dose of BTs can modulate the bovine respiratory microbiota, highlighting that microbiome-based strategies have the potential in being utilized to mitigate BRD in feedlot cattle.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility test methods from upper respiratory tract samples in predicting the outcome of tulathromycin control or treatment of bovine respiratory disease in high risk feeder heifers
J. J. Sarchet, J. P. Pollreisz, … P. Taube·bioRxiv·Feb 4, 2021
- Mucosal architecture, microbiota resilience and metabolic disruption reveal holobiont dynamics during bovine respiratory disease
Sergio Mendez, Guenaelle Derolez, … Núria Mach·bioRxiv·Oct 5, 2026
- Gut and nasal microbiome trajectories shape respiratory disease severity in calves exposed to antibiotic and pathogen challenge
Maverick Monié--Ibanes, Thomas Peyret, … Núria Mach·bioRxiv·Oct 17, 2026
- In vitro antimicrobial resistance in clinical isolates of bacterial pathogens causing bovine respiratory disease: a systematic review and meta-analysis
Qamer Mahmood, Philip Rasmussen, … Beate Conrady·bioRxiv·Sep 29, 2026
- Switching between bacteriostatic and bactericidal antimicrobials for retreatment of bovine respiratory disease (BRD) relapses is associated with an increased frequency of resistant pathogen isolation from veterinary diagnostic laboratory submissions
J. Coetzee, D. R. Magstadt, … A. M. OConnor·bioRxiv·Jun 18, 2019
- Efficacy of a new multivalent vaccine for the control of bovine respiratory disease (BRD) in commercial fattening units
Mariona Tapiolas, Marta Gibert, … Ricard March·VaccinesPeer-reviewed·Oct 29, 2024